Muttilainen S, Idänpään-Heikkilä I, Wahlström E, Nurminen M, Mäkelä P H, Sarvas M
Department of Bacterial Vaccine Research and Molecular Bacteriology, National Public Health Institute, Helsinki, Finland.
Microb Pathog. 1995 Jun;18(6):423-36. doi: 10.1006/mpat.1995.0038.
Class 1 outer membrane protein (P1) of Neisseria meningitidis group B is considered a promising vaccine candidate because P1 subtype-specific antibodies have been shown to be protective in an animal model. We have previously described the production of P1 in the Gram-positive Bacillus subtilis as intracellular inclusion bodies, from which the protein (BacP1) is easily purified (Nurminen et al., Mol. Microbiol., 1992, 2499-2506). We show here that the purified BacP1 can be reconstituted into phospholipid vesicles with the formation of the native immunodominant surface epitopes. The detergent-solubilized, completely denatured BacP1 was fused with phospholipid-detergent micelles during detergent removal by dialysis or gel filtration to yield protein-lipid vesicles (liposomes). When mice were immunized with these liposomes, they produced high titers of antibodies reacting in a P1 subtype-specific manner with meningococcal cells indicating the presence of conformation-dependent P1-specific epitopes in the liposomes. The results suggest that a vaccine candidate for meningococcal disease could be developed from the BacP1-liposomes. They furthermore demonstrate the feasibility of refolding a denatured outer membrane protein, which has never been exposed to lipopolysaccharide, into a native-like conformation.
B群脑膜炎奈瑟菌的1类外膜蛋白(P1)被认为是一种很有前景的疫苗候选物,因为P1亚型特异性抗体在动物模型中已显示出具有保护作用。我们之前曾描述过在革兰氏阳性枯草芽孢杆菌中作为细胞内包涵体生产P1,从中可轻松纯化该蛋白(BacP1)(努尔米宁等人,《分子微生物学》,1992年,第2499 - 2506页)。我们在此表明,纯化后的BacP1可重构成磷脂囊泡,并形成天然的免疫显性表面表位。通过透析或凝胶过滤去除去污剂时,经去污剂溶解、完全变性的BacP1与磷脂 - 去污剂胶束融合,从而产生蛋白质 - 脂质囊泡(脂质体)。用这些脂质体免疫小鼠后,它们产生了高滴度的抗体,这些抗体以P1亚型特异性方式与脑膜炎球菌细胞发生反应,表明脂质体中存在构象依赖性的P1特异性表位。结果表明,可以从BacP1 - 脂质体开发出一种脑膜炎球菌病疫苗候选物。它们还证明了将从未接触过脂多糖的变性外膜蛋白重折叠成类似天然构象的可行性。